HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial

Edith A. Perez, Monica M. Reinholz, David W. Hillman, Kathleen S. Tenner, Matthew J. Schroeder, Nancy E. Davidson, Silvana Martino, George W. Sledge, Lyndsay N. Harris, Julie R. Gralow, Amylou C. Dueck, Rhett P. Ketterling, James N. Ingle, Wilma L. Lingle, Peter A. Kaufman, Daniel W. Visscher, Robert B. Jenkins

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial'. Together they form a unique fingerprint.

Medicine & Life Sciences